Exploring regulatory data sets of the Comirnaty vaccine - 11f

Where’s the plague?

Yes, we are back on the Comirnaty series; even old geezers need some light relief. 

This post is brief; the first part has a background, some facts, and a question. There’s a short second part with what we think is remarkable about the facts. Not clear? Wait.

Part 1 

In July 2024, we posted this, 11d in the Comirnaty series: 

Exploring regulatory data sets of the Comirnaty vaccine - 11d

In it, we explained some of the uses of data from placebo arms in randomised controlled trials. Although controlled (as in, run by researchers following a protocol) and on selected populations, placebo arms tell you much about what is going on without the intervention (drug, vaccine, device, whatever). A real placebo is an inert substance that is visually the same as the real stuff. In the Comirnaty case, it was a saline placebo.

So in 11c 

Exploring regulatory data sets of the Comirnaty vaccine - 11c

and 11d, we looked at the definition of the effectiveness outcomes (vague) and the incidence of Covid according to the Pfizer BioNTech trial, which was very low. At the time, we were looking at mid-2021 data presented to regulators.